Given the potential utility of PLD2 inhibitors for cancer and acute thrombotic disease, in particular in combination with PLD1 inhibitors2, an effect on blood pressure represents a topic that should be assessed carefully if and when PLD2 inhibitors enter the clinic. Here, PLD1 is linked to cancer.